Correlation between antiplatelet resistance and recurrent cardiac ischemic events of patients with acute myocardial infarction

National Medical Journal of China

Volumn 92, Issue 38, 2012, Pages 2677-2680

  Li, Lei ^a   Han, Jiang Li ^a   Li, Hai Yan ^a   Qiao, Rui ^a   Yu, Hai Yi ^a   Zeng, Hui ^a   Gao, Wei ^a   Zhang, Jie ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Aspirin resistance; Clopidogrel resistance; Drug resistance; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; CLOPIDOGREL;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL EVALUATION; CONTROLLED STUDY; CORONARY STENT; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PLATELET REACTIVITY; PREDICTIVE VALUE; PREDICTOR VARIABLE; RECURRENT DISEASE; STENT THROMBOSIS; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT;

AGED; ASPIRIN; DRUG RESISTANCE; ELECTRIC IMPEDANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PREDICTIVE VALUE OF TESTS; RECURRENCE; TICLOPIDINE;

EID: 84876507792     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2012.38.005     Document Type: Article

References (18)

1. Kushner F G, Hand M, Smith S C J, et al. 2009 focused updates; ACC/AHA guidelines for the management of patients with ST elevation myocardial infarction and ACC/AHA/SCAI guidelines on percutaneous coronary intervention. J Am Coll Cardiol, 2009, 54: 2205-2241.
2. Ben-Dor I, Kleiman N S, Lev E. Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy. Am J Cardiol, 2009, 104: 227-233.
3. Lev E I, Patel R T, Maresh K J, et al. Aspirin and Clopidogrel Drug Response in Patients Undergoing Percutaneous Coronary Intervention. The Role of Dual Drug Resistance. J Am Coll Cardiol, 2006, 47: 27-33.
4. Anderson J L, Adams C D, Antman E M, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction. J Am Coll Cardiol, 2007, 50: e1-e157.
5. Antman E M, Hand M, Armstrong P W, et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction. Circulation, 2008, 117: 296-329.
6. American Diabetes Association. Clinical Practice Recommendations 2005. Diabetes Care, 2005, 28: s1-s79.
7. Velik-Salchner C, Maier S, Innerhofer P, et al. Point-of-care whole blood impedance aggregometry versus classical light transmission aggregometry for detecting aspirin and clopidogrel: the results of a pilot study. Anesth Analg, 2008, 107: 1798-1806.
8. 2007, 30: 1260-1265.
9. Cutlip D E, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials; a case for standardized definitions. Circulation, 2007, 115: 2344-2351.
10. Gori A M, Marcucci R, Migliorini A, et al. Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents. J Am Coll Cardiol, 2008, 52: 734-739.
11. Schneider D J. Factors contributing to increased platelet reactivity in people with diabetes. Diabetes Care, 2009, 32: 525-527.
12. Ferreiro J L, Gómez-Hospital J A, Angiolillo D J. Platelet abnormalities in diabetes mellitus. Diab Vase Dis Res, 2010, 7: 251-259.
13. El Ghannudi S, Ohlmann P, Jesel L, et al. Impaired inhibition of P2Y12 by clopidogrel is a major determinant of cardiac death in diabetes mellitus patients treated by percutaneous coronary intervention. Atherosclerosis, 2011, 217: 465-472.
14. Snoep J D, Hovens M M, Eikenboom J C, et al. Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis. Am Heart J, 2007, 154: 221-231.
15. Krasopoulos G, Brister S J, Beattie W S, et al. Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and metaanalysis. BMJ, 2008, 336: 195-198.
16. Kaltoft A, Jensen L O, Maeng M, et al. 2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry). J Am Coll Cardiol, 2009, 53: 658-664.
17. Smit J J J, van't Hof A W J, de Boer M J, et al. Incidence and predictors of subacute thrombosis in patients undergoing primary angioplasty for an acute myocardial infarction. Thromb Haemost, 2006, 96: 190-195.
18. Lev E I, Patel R T, Maresh K J, et al. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention; the role of dual drug resistance. J Am Coll Cardiol, 2006, 47: 27-33.